2m 2m 2m 2m 2m 2m 2m
MAXCYTE (MXCT)
NASDAQ
$1.20-$0.03 (-2.52%)
Price as of Jun 03, 2026 6:44 PM EDT- $129.6MMarket Cap
- -46.05%1-Year Change
- Medical DevicesIndustry
MAXCYTE (MXCT)
$1.20-$0.03 (-2.52%)
MXCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.23 | ||
Change | +$0.01 (+0.82%) | ||
Open | $1.20 | ||
High | $1.24 | ||
Low | $1.14 | ||
Previous Close | $1.22 | ||
Volume | 942,729 | ||
30-Day Average Volume | 1,253,557 | ||
1-Week Change | 23.00% | ||
1-Month Change | 39.77% | ||
1-Year Change | -46.05% | ||
3-Year Change | -71.85% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 107.1M | ||
Total Assets | $194.5M | ||
Market Cap | $129.6M | ||
Enterprise Value | $115.1M | ||
Period: QTR TTM FY | |||
Revenue | $9.7M | ||
Net Income | -$4.8M | ||
Free Cash Flow | -$8.2M | ||
EBIT | -$4.8M | ||
EBITDA | -$3.7M | ||
Net Working Capital | $112.7M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 1 | ||
P/E | -30 | ||
PEG | -1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue